- Analysis Finds that Medications for Hepatitis C and HIV/AIDS Are the Costliest Group of Outpatient Prescription Drugs for Medicaid, While Diabetes Drugs Have Posted the Sharpest Rise in Costs
- Utilization and Spending Trends in Medicaid Outpatient Prescription Drugs
- Long-Term Trends in Employer-Based Coverage
- Medicare Part D Enrollees with Serious Health Conditions Can Face Thousands of Dollars in Out-of-Pocket Costs Annually for Specialty Drugs
- Medicare Part D Enrollees with Serious Health Conditions Can Face Thousands of Dollars in Out-of-Pocket Costs Annually for Specialty Drugs
- 10 Essential Facts About Medicare and Prescription Drug Spending
- The Out-of-Pocket Cost Burden for Specialty Drugs in Medicare Part D in 2019
- The Out-of-Pocket Cost Burden for Specialty Drugs in Medicare Part D in 2019
- The Uninsured and the ACA: A Primer – Key Facts about Health Insurance and the Uninsured amidst Changes to the Affordable Care Act
- Poll: Majorities Favor a Range of Options to Expand Public Coverage, Including Medicare-for-All
- KFF Health Tracking Poll – January 2019: The Public On Next Steps For The ACA And Proposals To Expand Coverage
- How Does Cost Affect Access to Care?
- How Do Health Expenditures Vary Across the Population?
- Initiative 18|11: What Can We Do About The Cost Of Health Care?
- Larry Levitt Answers 3 Questions on Calif. Governor’s Proposed Individual Mandate, Expanded Subsidies
Information & News
CategoriesComments & Posts